Article metrics
PDF
Other content recommended for you
- Changes in diagnosis with follow-up in an incident cohort of patients with parkinsonism
- Impact of DaTscan SPECT imaging on clinical management, diagnosis, confidence of diagnosis, quality of life, health resource use and safety in patients with clinically uncertain parkinsonian syndromes: a prospective 1-year follow-up of an open-label controlled study
- 123I-FP-CIT SPECT in dementia with Lewy bodies, Parkinson’s disease and Alzheimer’s disease: a new quantitative analysis of autopsy confirmed cases
- A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes
- Neurodegenerative disorders: Parkinson’s disease and Huntington’s disease
- Patients with Alzheimer's disease and dementia with Lewy bodies mistaken for Creutzfeldt-Jakob disease
- Parkinson's disease: chameleons and mimics
- Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromes
- Both total and phosphorylated tau are increased in Alzheimer's disease
- Open questions on the nature of Parkinson’s disease: from triggers to spreading pathology